Referencer
- Kleresca® Rosacea Treatment Instruction for Use
- Edge, D. Et al. Fluorescent Light Energy: the future for treating inflammatory skin conditions? J Clin Aesthet Dermatol. 2019;12(5):E61–E68
- Jalili, A. 2018. Chromophore gel-assisted phototherapy. A novel and promising photobiomodulation therapy for facial inflammatory skin diseases and skin aging. J Ästhet Chir. 2018. Early online 20 February
- Nikolis, A. et al. An extension of a multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int. J. Dermatol. 2017; Accetped
- Antoniou, C.et al . A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. 2016; Int J Dermatol, 2016, 55; 1321 – 1328
- Mahendran, A. et al. Treatment of erlotinib‐induced acneiform eruption with chromophore gel‐assisted phototherapy. Photodermatol Photoimmuno Photomed, 2018, 1-3
- Nikolis, A., et al . A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation. Clinical, Cosmetic and Investigational Dermatology, 2016; 9, 115–25.
- Scarcella et al. 2018,. Treatment of solar lentigines using a combination of PICO-Laser and Biophotonic treatment. Clin Case Rep. 2018;00:1–3.
- Braun, S.A.& Gerber, P. A photoconverter-gel assited blue light therapy for the treatment of rosacea. Int J Dermatol. 2017 Dec;56(12):1489-1490
- Sannino, M. et al. A novel platform for treating rosacea subtypes 1, 2 and 3 using fluorescent light. Clin Case Rep. 2018;00:1–6.
- Liu, R.C. et al. Treatment of granulomatous rosacea with chromophore gel-assisted phototherapy. Photodermatol Photoimmunol Photomed. 2019;1–2.
- Wade et al. 2019 Kleresca® Biophotonic therapy decreases facial eythema, improves the signs and symptoms of rosácea and increases patient satisfaction: A post-market study (In Press)
- Nielsen, Schoedt & Bak-Christensen. Clinical Evaluation – Kleresca® Biophotonic Treatments. 2017. Kleresca® Data on File
- Wilkin, J., et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004 Jun;50(6):907-12.
- Wilkin, J., et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002 Apr;46(4):584-7.
- Zeichner, A., et al. Quality of Life in individuals with erythematotelangiectatic and papulopustular rosacea: findings from a web-based survey. J Clin Aesthet Dermatol. 2018; 11(2):47 – 52
- Say, E.M., et al. Treatment Outcomes of Long-Pulsed Nd: YAG Laser for Two Different Subtypes of Rosacea. J Clin Aesthet Dermatol. 2015 Sep;8(9):16-20.
- J. Spoendlin, J. J. Voegel, S. S. Jick, C. R. Meier. (2012, September). A study on the epidemiology of rosacea in the U.K. British Journal of Dermatology, 167(3), 598-605.
- Gether. L et al. Incidence and Prevalence of Rosacea: a systematic review and meta-analysis. Br. J. Dermatol 2018 [Epub ahead of print]
- Stanisław Jarmuda, Niamh O’Reilly, Ryszard Z˙aba, Oliwia Jakubowicz, Andrzej Szkaradkiewicz and Kevin Kavanagh. (2012). Potential role of Demodex mites and bacteria in the induction of rosacea. Journal of Medical Microbiology, 61, 1504–1510.
- Thomas Jansen and Gerd Plewig. (1997). Rosacea: classification and treatment. Journal of the Royal Society of Medicine, 144-150.
- National Rosacea Society. Widespread Facial Disorder May Be Linked to Genetics.www.rosacea.org/press/archive/20080602.php. Retrieved May 2018.
